Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 2 1Phase 1/2 1

Status

Completed 21Recruiting 9Terminated 7Unknown 4Active not recruiting 4Withdrawn 3Suspended 1

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 4Sarcoma 1

Conditions

Central Nervous System Neoplasms 5Glioblastoma 4Brain Neoplasms 3Astrocytoma 3Lymphoma 2Glioma 2Spinal Cord Neoplasms 1Recurrence 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma, Large-Cell, Anaplastic 1Gliosarcoma 1

Interventions

Temozolomide 44Radiotherapy 16Bevacizumab 9Surgical Procedures, Operative 5Carmustine 5Lomustine 4Drug Therapy 4pembrolizumab 3Sunitinib 3Standard of Care 3Radiation 3Procarbazine 3Irinotecan 3Granulocyte-Macrophage Colony-Stimulating Factor 3Chlorotoxin 3Carboplatin 3Blood Specimen Collection 3tislelizumab 2fludarabine 2camrelizumab 2Radiosurgery 2Neoadjuvant Therapy 2Magnetic Resonance Spectroscopy 2Hyperbaric Oxygenation 2Ethanol 2Cyclophosphamide 2Chemotherapy, Adjuvant 2CT-322 2Bortezomib 2Aminolevulinic Acid 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Glioblastoma × Lomustine × Clear all
NCT04573192 2024-04-08

GLIOSTAR

Philogen S.p.A.

Phase 1/2 Unknown
142 enrolled
CNS

Glioblastoma

NCT03025893 2021-04-19

STELLAR

Amsterdam UMC, location VUmc

Phase 2/3 Unknown
100 enrolled
CNS

Brain Neoplasms, Glioblastoma

NCT00003788 2013-11-06

Surgery, Radiation Therapy, and Chemotherapy With or Without Photodynamic Therapy in Treating Patients With Newly Diagnosed or Recurrent Malignant Supratentorial Gliomas

National Cancer Institute (NCI)

Phase 3 Unknown
270 enrolled
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT01737346 2012-12-03

Procarbazine and Lomustine in Recurrent Glioblastoma

Incheon St.Mary's Hospital

Phase 2 Unknown
52 enrolled
CNS

Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡